NEW YORK, Sept. 29, 2015 /PRNewswire/ -- At the Dr. Samadi Prostate Cancer Center, Dr. Samadi performs each MRI-Fusion Guided Prostate Biopsy procedure, ensuring patients receive expert diagnostic care for prostate cancer.
MRI Guided Biopsy is a new technique which makes for a much more accurate diagnosis, especially when it comes to the staging of prostate cancer, but often a radiologist technician performs the procedure. Dr. Samadi performs every procedure and provides expert, unbiased diagnostic analysis of the results.
The Dr. Samadi Prostate Cancer Center is one of the only centers in New York City with the revolutionary Uronav Fusion Biopsy System from Invivo.
"I take a lot of pride in performing every procedure. In some cases patients aren't able to interact with the Prostate Cancer Specialist during diagnostic testing, but we want to give piece of mind to every man and also the opportunity to ask questions directly to me," said Dr. Samadi, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital.
Dr. Samadi also performs MRI Fusion Guided Biopsy to help men with an elevated PSA in order to rule out prostate cancer. Integrating the use of an MRI makes for a much more accurate diagnosis of a cancer presence.
"We're very pleased to now offer the benefit of this advanced technology to our patients. Men come to us with an elevated PSA and if a biopsy permits, the use of the MRI guides us to target specific areas of the prostate that show potential lesions. As opposed to a random biopsy, fusion biopsy is a much smarter approach to diagnosing the disease and also how aggressive the cancer may be," stressed Dr. Samadi.
An MRI-ultrasound fusion biopsy involves taking an MRI and then fusing the data with real-time ultrasound images for guidance on biopsy procedures. The UroNav System combines electromagnetic tracking and navigation with an onboard computer and a real-time imaging interface in one mobile workstation. As seen in the image, MR/Ultrasound fusion aligns and registers prior diagnostic MR images (bottom) with real-time ultrasound images (top). The red outline displays the segmented prostate anatomy from the MR exam and blue/red "targets' indicate the location of the MR suspicious lesions on the prostate.
Dr. Samadi expressed that in the past prostate cancer wasn't always diagnosed using advanced imaging but believes targeted MR/Ultrasound biopsy is poised to become the new standard in prostate care. "For prostate biopsies, the technology hasn't changed since the 1980s. Conventional techniques like a random biopsy only examine the lower area of the prostate. But many cancers we find are in locations outside of that zone."
MRI fusion-guided biopsy continues to improve accuracy for diagnosing prostate cancer and it also is proving to be a more effective method for detecting and diagnosing high-risk and aggressive prostate cancers.
In a new study from the National Cancer Institute, 1003 men with elevated PSA levels studied over a seven year period, underwent a targeted and standard biopsy. Targeted MR/Ultrasound fusion biopsy diagnosed 461 prostate cancer cases and standard biopsy in 690 men. The targeted biopsy diagnosed 30% more high risk cancers versus standard biopsy. The result showed an increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer. In addition 17 percent fewer low-risk cancers were diagnosed. This study concludes the fusion of MR/Guided and Standard Biopsy can diagnose intermediate- to high-risk prostate cancer.
"We can see the entire gland. In a targeted biopsy, MRIs of the suspected cancer fused with real-time ultrasound images create a map of the prostate that enables both urologists and radiologists to pinpoint and test suspicious areas of the prostate region," noted Dr. Samadi.
Patients newly diagnosed with prostate cancer can contact world renowned prostate cancer surgeon and urologic oncologist, Dr. David Samadi, for a free phone consultation and to learn more about an MRI Guided Biopsy. Call 212.365.5000 to set up your consultation.
Video - http://youtu.be/gRlORbLK5pk
SOURCE Dr. David Samadi